HLS Therapeutics
Caledon
About HLS Therapeutics
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity. HLS ensures the availability of treatments critical to patients and their caregivers with the brand names they trust.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $361.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2024)
- Ticker: tsx:HLS
- Website: hlstherapeutics.com
- Phone: +1 (416) 624-6568
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hls-therapeutics-35947 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.